In contrast, for non-LAD lesions, FFR guidance showed a trend toward benefit, but the difference did not reach statistical significance (7.4% vs. 14.5%; p = 0.081).
2
—
—
The sentences
Moreover, the incidence of target lesion myocardial infarction was numerically lower in LAD lesions (1.45%) than in LCx (4.09%) and RCA (2.05%), although this did not reach statistical significance.